Daily news email for September 22, 2015 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
BioOutsource Ltd. Acquired by Sartorius Stedim Biotech

Sartorius Stedim Biotech Acquires UK-Based CRO, BioOutsource

Selvita to Release the Most Recent Results from Its Oncology Programs at the AACR Annual ...

Isarna Initiates First-in-Human Phase I Trial for ISTH0036 to Treat Advanced Glaucoma

Positive Clinical Study Results for Cellmid's Hair Growth Product Using Novel FGF5 Inhibitor

BioSpace
NeuroVive Chooses New Stroke Partner After To-BBB's Restructuring and Collaboration Concludes

The Number One Cause Of Depression - Everywhere

A Dog's Life: Study Reveals People's Hormonal Link With Tail-Waggers

E-Cigarette Flavoring Chemicals May Pose Risks When Inhaled, Study

Fatal Brain Disease In U.S. Man Likely Came From UK Beef

BioSpace - Breaking News
Full Data On Baxter International's Investigational Recombinant Treatment BAX 111 Supports Potential Role To Treat Von Willebrand Disease

4SC Pockets €95 Million Upfront From Resminostat Deal With Menarini Asia-Pacific Group (Formerly Invida Group)

PharMerica Announces First Quarter 2015 Earnings Call And Webcast

Amerigen Pharmaceuticals Announces Tentative Approval Of Generic Bystolic

Ariad Presents Updated Clinical Data On Brigatinib In Patients With ALK+ Non-Small Cell Lung Cancer

Biotech News - Business Wire
Ignyta Announces Multiple Presentations at the 2015 AACR Annual Meeting

Meeting the Needs of Ophthalmologists: ZEISS Showcases Integrated Solutions that Deliver Faster Practice and Surgical Workflow and Address Critical Diagnostic Challenges

SanBio Presents at Annual European Stroke Organisation Conference

La bioéconomie du Canada, en pleine croissance, sera la vedette du Congrès mondial BIO 2015 sur la biotechnologie industrielle, organisé à Montréal

A Cure for Global Warming plus Drought Relief

Biotech News - PR Newswire
Sorrento Therapeutics Announces Three Preclinical Poster Presentations on Cynviloq, its Novel Antibody Drug Conjugate Linker Technology and c-Met/EGFR Bispecific ADC at the 106th Annual Meeting of the American Association for Cancer Research

Aurigene to Present its NAMPT and IRAK-4 Inhibitors Programs at AACR 2015

21st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry

AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc.

Centrillion Receives NIH Funding for Genomic Technology Development

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
Pfizer Ups Offer for AstraZeneca to $119B

FDA Rejects Novartis Serelaxin for Acute Heart Failure

Abbott Buys Chile's CFR Pharmaceuticals for $2.9B

Shedding Non-Core Assets

Expanding the Building Blocks of DNA

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
STENTYS Self-Apposing® Stent Demonstrates Lowest Mortality Rate Among Large Heart Attack Trials

Enzo Biochem Schedules Teleconference to Discuss Second Quarter Results on March 13, 2013 at 8:30 AM E.T.

Research and Markets: Thromboembolism Global Clinical Trials Review, H1, 2013

RegeneRx Receives Notice of Allowance for 2nd U.S. Heart Patent

Trevena to present results of TRV027 Phase 2a Study in Patients with Advanced Heart Failure

Clinical Trials - PR Newswire
Aaron Ciechanover, Israel Cancer Research Fund "Research Professor" Announces Breakthrough in Cancer Research

PRN's Omega-3 Hits Major Endpoints Against Placebo in a Study of Dry Eye Symptoms

MabVax Therapeutics Analyst Brief by ARCE Research: Creating the Techniques to Fight Cancer in the Future Issued by BrokerBank Securities, Inc.

Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology

Restoring Cellular Energy Signals May Offer Promise of Treating Mitochondrial Diseases in Humans

CNN Top Stories
Scarlett O'Hara's dress sells for $137,000

Your medical marijuana questions answered

Lawyer releases reserve deputy's training records

2.25 tons of cocaine seized

92,000 Mini Coopers recalled

Contract Pharma
RXi Pharmaceuticals Receives Orphan Drug Designation

Cipher Pharmaceuticals Enters U.S. Market

BioOutsource Acquired by Sartorius Stedim Biotech

Sagent Appoints President

EMD Serono Appoints Global Clinical SVP

FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: La FDA refuerza las advertencias y cambia las instrucciones de prescripción para reducir el riesgo de sufrir reacciones alérgicas graves con el medicamento para la anemia Feraheme (ferumoxitol)

CDER Key Officials List

FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol)

Comunicado de la FDA sobre la seguridad de los medicamentos: La FDA advierte de una reducción grave de la frecuencia cardiaca cuando se usa el medicamento antiarrítmico amiodarona junto con tratamientos contra la hepatitis C que contienen sofosbuvir (Harvoni o Sovaldi), en combinación con otro fármaco antivírico de acción directa

FDA Drug Safety Communication: FDA warns of serious slowing of the heart rate when antiarrhythmic drug amiodarone is used with hepatitis C treatments containing sofosbuvir (Harvoni or Sovaldi) in combination with another Direct Acting Antiviral drug

FDA News - Business Wire
Meeting the Needs of Ophthalmologists: ZEISS Showcases Integrated Solutions that Deliver Faster Practice and Surgical Workflow and Address Critical Diagnostic Challenges

Full Data on Baxter's Investigational Recombinant Treatment BAX 111 Supports Potential Role to Treat von Willebrand Disease

Pernix Therapeutics Inc. to Report First Quarter 2015 Financial Results

FDA Approves Only ICD with Ultra-High Energy on the First Shock

TransEnterix Announces Completion of GLP Studies

FDA Press Releases
FDA approves first-of-its-kind corneal implant to improve near vision in certain patients

FDA approves first generic Copaxone to treat multiple sclerosis

U.S. Marshals seize unapproved drugs from Florida distributor

FDA approves Corlanor to treat heart failure

FDA warns consumers not to use muscle growth product called Tri-Methyl Xtreme

FDA Vaccines, Blood and Biologics - What's New
Summary Basis for Regulatory Action, June 2, 2014 - Ruconest

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine

Draft Guidance for Industry: Considerations for the Design of Early-Phase Clinical Trials of Cellular and Gene Therapy Products

Guidance Agenda: Guidance Documents CBER is Planning to Publish During Calendar Year 2014

Guidance for Industry: BLA for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic and Immunologic Reconstitution in Patients with Disorders Affecting the Hematopoietic System

FierceBiotech
Drew Fromkin tapped to lead Langer's Blend Therapeutics

Sanofi and Innate Pharma team up on anti-cancer ADCs

Takeda inks a $270M stem cell deal with Kyoto University

The FDA calls on Genervon to release data from controversial ALS study

AstraZeneca's '$3B' lung cancer drug impresses in a Phase II race with Clovis

FierceBiotech IT
California starts statewide precision medicine initiative with Atul Butte at the helm

Apple, IBM team up for Watson-fueled assault on health research

Biopharma puts better use of existing data at top of R&D wishlist

PatientsLikeMe adds AstraZeneca to growing list of big name clients

Peking University inks Medidata deal as China inches into eClinical era

FierceBiotech Research
UCLA team packs large cargo into cells

Focused on cell signaling, CHOP team preps for human mitochondrial drug study

Scripps Parkinson's study points to a key enzyme as a potential drug target

Frick scientists identify melanoma's 'safe haven,' and a combo to destroy it

MIT team works on amping-up a new approach to cancer immunotherapies

FiercePharma
BMS' PD-1 drug Opdivo continues on stellar trajectory

Merck KGaA shareholders rewarded for hard work of turning company around

Analyst: Vivus generic threats a positive for obesity market

GSK closing Pittsburgh office, putting 275 jobs at risk

BMS, focused on immuno-oncology, turns Erbitux over to Eli Lilly

FiercePharma Manufacturing
Norwich Pharma spending $26M on new equipment

Catalent Kentucky expansion grows to $52M

Sanofi Pasteur U.S. operation part of dengue vaccine buildup

Bayer to pump $100M into U.S. facility focused on hemophilia drugs

GSK plant in Ireland making headway on reducing carbon footprint

FierceVaccines
Study: Serum Institute's powdered measles vaccine inferior to traditional jab

Healthcare systems could benefit from covering HPV vaccine in boys, study says

Merck takes its Ebola vaccine to Phase III in Sierra Leone

Aduro swings for the fences with $119M IPO

Janssen looks to Ichor's electroporation delivery system for hep B jab

Health News - BizJournals.com
Inside the Denver VA hospital that will require another $340M in 'activation costs' (Slideshow)

Founder says Panasci winner could be "a rapid growth biotech company"

Finalist for Colorado health exchange CEO withdraws

Wilcox Memorial Hospital CEO Kathy Clark to retire from Kauai hospital this summer

Moffitt biotech conference: Opportunities ahead in personalized care, improved treatment diagnostics

Health News - CNBC
Germany's Merck Serono to produce medicines in UAE

Germany's Merck Serono to produce medicines in UAE

Analysis: Drugmakers step up search for hearing loss medicines

Grand jury probing meningitis-linked pharmacy: newspaper

Small Employers Weigh Impact of Providing Health Insurance

Health News - Fox Business
BMW recalling 91,800 Mini Coopers to repair defect affecting front passenger air bag

Recalls this week include blowers, mowers, bike hooks, mattresses, toys, utility vehicles

Pharmaceuticals companies shares mixed at the close of trading

Managed Care companies shares down at the close of trading

Health Care Equipment companies shares down at the close of trading

Inside Industry - Gen
McKesson's $8.3B Celesio Deal Builds Drug Warehousing Powerhouse

DSM, Sanquin Make Factor IX-Recovering mAb Manufacturing Deal

Startup Wins Five-Year Exclusive License to deCODE Genetics Platform

Cleveland BioLabs Subsidiary Awarded $4.6M Russian Contract

Imugene Acquiring Biolife, as Lead Pipeline Candidate Nears Phase II

Marketwire - Pharma and Biotech
HVAC Unit Arrives in Nova Scotia for Installation

BlueOcean NutraSciences Announces the Close of the Non-Brokered Private Placement

La Cour supr du Canada donne raison heratechnologies

Supreme Court of Canada Rules in Favour of Theratechnologies

In Lieu of ROI Numbers, Medical Information Teams Rely on Key Performance Indicators to Track Pharmaceutical Call Center Performance

MassBio News
MassBio Welcomes Seven New Board Members

MassBio to Host Art in Giving: Exhibit XX

Patient Profile: Promise for a Better Future

Patients are Rare Alone, Strong Together

The MassBio Employee Perks Program is Expanding

Medical Pharma - PR Newswire
Jeb Bush's Suggestion to Require Medicare Recipients to Complete Advance Directives Called "Step in Right Direction"

Health Canada proposes new measures to address antimicrobial resistance

Contego Medical Closes $5.6 Million in Series B Funding

Diplomat Launches National Search for Internship and Fellowship in Flint

Lima Corporate fait l'acquisition des prothèses unicompartimentales et totales du genou pour les marchés européens

National Center for Biotechnology Information
MedGen News

NCBI Announcements

NCBI News

NLM Catalog New and Noteworthy

PubMed Central News

Nature Biotechnology
NIH innovation investment pays

Dogs, humans and lymphoma therapy

Rebooting review

IDO inhibitors move center stage in immuno-oncology

Apple's ResearchKit frees medical research

New York Times- Biotechnology
Seeking Support, Biotech Food Companies Pledge Transparency

A High-Tech Menagerie

Cornell Scientist’s Quest: Perfect Broccoli

After Patent Ruling, Availability of Gene Tests Could Broaden

Connecticut Approves Labeling Genetically Modified Foods

New York Times- Pharmaceuticals
A Dry Pipeline for Psychiatric Drugs

Death Row Improvises, Lacking Lethal Mix

A Musical Switch From Self-Pity to Gratitude

Warning: This Pill May Be Dangerous to Your Health

To Judge Sleep Aids, U.S. Looks at Drowsy Driving in the Morning

OnBioVC
Every New Beginning

OptiMedica, Corp.: Series E $35M

iRythm Technologies, Inc.: Series C $1.5M

Edison Pharmaceuticals, Inc.: Series F $20M

New Haven Pharmaceuticals, Inc.: Series A $6.6M

Outsourcing-Pharma
Happy Holidays 2014 from William Reed Business Media!

A bitter pill to swallow: young people dislike tablets more than old

Consolidation prevalent in industry, says third largest CMO

Catalent commits to ADCs by upping its stake in Redwood

Catalent commits to ADCs by upping its stake in Redwood

Pharma News - Business Wire
Ignyta Announces Multiple Presentations at the 2015 AACR Annual Meeting

SanBio Presents at Annual European Stroke Organisation Conference

AptarGroup Declares Quarterly Dividend

Breast Cancer Survivors and Advocates Call on Congress to Maintain Commitment to Breast Health Care Access, Ensure Treatment Parity

Des essais mondiaux démontrent que lajout dune procédure de thrombectomie avec stent Solitaire de Medtronic au traitement dAVC ischémiques aigus améliore les résultats neurologiques

Pharma News - PharmiWeb
Ignyta Announces Multiple Presentations at the 2015 AACR Annual Meeting

Meeting the Needs of Ophthalmologists: ZEISS Showcases Integrated Solutions that Deliver Faster Practice and Surgical Workflow and Address Critical Diagnostic Challenges

SanBio Presents at Annual European Stroke Organisation Conference

A Cure for Global Warming plus Drought Relief

MEDIA ADVISORY: Assemblymember Linda B. Rosenthal AARP Team up to Announce Major Step for 4M Family Caregivers

Pharma News - PR Newswire
Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle

Pharmaceutical Industry Struggling to Better Serve Provider Networks Such as Accountable Care Organizations (ACOs)

Mylan Comments on Recent Media Speculation

Lysine Market International (US, Europe, Japan) Research Analysis

Federal Circuit Upholds Mylan's U.S. Patents on Perforomist® Inhalation Solution; Decision Prevents Approval of Teva ANDA

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Hello Bio launches new website - supporting researchers worldwide

Dr. Frederik Pennings Joins AccelSPINE Medical Advisory Board

Accentuate Staffing Announces New Business Line, R&D Consulting Division Offers Executive Level Placement Services to the Life Science Community

Qutromtech developed a life saving drugs

Trevigen Inc. Awarded Prestigious Grant to Bring CometChip™ to Market

PRWeb - Biotechnology
Reed Tech Announces FDA Lot Distribution Report (LDR) Service for...

Hemodynamic Monitoring Systems Market to Reach $1,107.4 Million by...

MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life...

Providence Fertility Center Physicians Will Be Featured on WPRI 12's...

Software Defined Data Center Market Reaches $77.18 Billion by 2020...

PRWeb - Pharmaceuticals
DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management...

Testosterone Treatment Lawsuits Increase, as New Report Indicates Over...

Global Hepatitis (A, B) Vaccine Market Analysis Report 2015-2020

First ConCert by HIMSS certified Ambulatory EHR and Patient...

Reducing Drug and Device Batch Release Times: Expert Reveals Secrets...

Scientific American
China Risinga Burgeoning Industrial Superpower Built on Coal [Excerpt]

The Enduring Mystery of the Missing Oil Spilt in the Gulf of Mexico

Alien Supercivilizations Absent from 100,000 Nearby Galaxies

Fateful Phone Call Spawned Moore's Law [Excerpt]

Is the Gaze from Those Big Puppy Eyes the Look of Your Doggie's Love

Sports - ESPN Basketball
UConn lands instantly eligible transfer Miller

Purdue C Hammons will return for final season

Fighting Illini add Charlotte transfer Thorne

Open-heart surgery successful for ISU's Hoiberg

K-State freshman Harris dismissed from program

Sports News - ESPN
Ohio St. draws 99,391 to set spring game record

Attorney: New NCAA head-injury deal just as bad

Time for Utah's Hunter Dimick to make superhero transition

UNC's defense won't be an easy fix

Jake Brendel keeps UCLA's line moving

Xconomy Life Sciences
Rice Business Plan Competition Adds People's Choice Award

Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups

Dip, But No Slowdown in First-Quarter VC Funding, & Top 10 Deals

West Coast Biotech Roundup: CRISPR, Doudna, Aduro, Amgen, NEA & More

Early Bird Ends Today for Houston 2035: Innovating the City's Future

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)